#1. The Plant.
Crila® is made from the patented cultivar of Crinum latifolium – Crinum latifolium L var. crilae Tram & Khanh. Over 200 different sources of crinum have been tested and all are found to lack key ingredients present only in the unique crinum latifolium used to make Crila®. Years ago, before making a substantial investment to bring Crila® to market, Crila Health conducted DNA testing on these plants. This kind of testing is absolutely necessary to confirm the Botanical Authentication of specific plants. Many species look exactly alike unless you’re an expert Ethnobotanist. Testing confirms the Crila® plants contain unique properties not found in other commercial crinums. Period. Full Stop.
#2. Farm – Factory – Finished Product.
Farm-to-Factory-to-Finished Product means Crila® follows the industry’s “Best Practices” model most companies only dream about. There’s no outside sourcing of the key ingredients in Crila®. Apart from the fact other growers don’t have these unique plants, the farm-factory-finished product process means we know exactly how they’ve been grown. If you buy dried herbs from an outside farmer, you can’t be certain that farmer follows your standards. He might sneak into the field at midnight to spray with a pesticide, or use a chemical fertilizer, to increase his yield. It will show up in the testing, but that’s late in the game. It’s just too risky. Numbered sections of the Crila® plantations means we can trace each batch to exactly where it was grown. Remember, it takes years for the plants to reach the biological maturity essential for the alkaloids and flavonoids that make Crila® effective. Think of it like fine wine. You can’t plant new vines this year and make vintage Cabernet Sauvignon next year.
#3. Laboratory Testing.
It’s necessary to test to know what’s in your product. And it’s the law. Every batch of Crila® is tested twice before shipped to the U.S. Once by the factory’s inhouse lab, certified to GMP standards set by the World Health Organization; then again, at an independent government laboratory under the Ministry of Health. We test in American labs too. We disclose on Crila Health’s website our testing for lead, heavy metals, allergens, and pesticides at the Eurofins laboratories in Metairie, Lousiana. Multiple batch testing has also been conducted, and is ongoing, at UIC (the University of Illinois Chicago, College of Pharmacy) that confirms Crila® is Estrogen Free.
We were recently asked by a reader to clarify the difference between Crila® and a cheap crinum product sold by Swanson. By law, Swanson’s has to test too. If you were a Swanson customer in California who ordered the Swanson crinum product off the Amazon website, you’d get a refund about a week later with apologies that Swanson can’t sell their crinum prostate product in California because it doesn’t pass Prop 65 testing. Prop 65 is a California law to protect consumers from chemicals and toxic substances that may cause cancer and birth defects. The full title is The Safe Drinking Water and Toxic Enforcement Act of 1986. If a company can’t meet the standards, it must include a notice on their label “This product contains chemicals known to the State of California to cause cancer and birth defects or other reproductive harm.” A common problem companies run into is California’s Prop 65 strict restrictions regulating lead and other heavy metals. Eurofins is the American lab we use to test Crila® for lead and heavy metals. Crila® passes. We sell to customers in California.
#4. The Crila® formula is an extraction.
Crila® is a patented extraction. To make an extraction, it is important to know what to leave IN and what to take OUT. The Crila® formula is the result of 26 years of research by Dr. Tram and her colleagues in Europe, and now the US, to identify not only the most beneficial components to concentrate in the formula, but also the non-beneficial, toxic, or even harmful components to remove. There are at least 9 essential biomarkers necessary to the Crila® formulation, two are disclosed on our label (see below: Transparent Labeling).
Other crinum plants often contain an element found in laboratory testing to be harmful to male sexual health. This element is not in Crila®. We have tested other crinum products on the market and found this harmful ingredient.
Swanson’s states their product is a full leaf powder so, by definition, it is not an extraction.
#5. Clinical Research.
Crila® is the only crinum to our knowledge that has been researched in published clinical trials. The studies on the key Crila® ingredient in our Prostate, Menopause and Uterine Health formulas were conducted and published by the Ministry of Health in Vietnam in 2005, and 2007 respectively; there is ongoing laboratory testing by UIC’s College of Pharmacy from 2014 to the present, presented at the North American Menopause Society 2015 convention in Washington, DC, and published in December 2015 Menopause.
An IRB-approved PAID clinical trial for menopause by Dr. Tori Hudson at A Woman’s Time clinic in Portland, OR is ongoing and still recruiting! Contact firstname.lastname@example.org if you want info to be considered for participation in this paid clinical trial. Another ongoing paid clinical trial, still open for further recruitment as of this writing, is for prostate patients of Dr. Mark Scholz, in Los Angeles, CA.
#6. Transparent Labeling.
Crila® labels disclose key information about the standardized extraction formula contained in our products. We don’t hide behind “a proprietary blend” that doesn’t tell you exactly”